Table 6 Risk of sclerosis in patients... | American Society of Hematology

Table 6

Risk of sclerosis in patients with chronic GVHD, according to recipient HLA-DP variations

Recipient variation	HR* (95% CI)	P
HLA-DPA1 rs987870 CC vs CT or TT genotypes	2.66 (1.18-5.97)	.02
DPA101:03∼DPB104:01 haplotype	1.59 (1.11-2.27)	.01
Q∼GPM P1 pocket†	0.64 (0.43-0.96)	.03

Recipient variation	HR* (95% CI)	P
HLA-DPA1 rs987870 CC vs CT or TT genotypes	2.66 (1.18-5.97)	.02
DPA101:03∼DPB104:01 haplotype	1.59 (1.11-2.27)	.01
Q∼GPM P1 pocket†	0.64 (0.43-0.96)	.03

Adjusted for stem cell graft source, HLA matching, ABO compatibility, TBI dose, and principal components.

Heterodimers with Q (glutamine) at position 31 of the HLA-DPα chain and GPM at positions 85 to 87 of the HLA-DPβ chain.